Revolution Healthcare Acq... (REVH)
NASDAQ: REVH
· Real-Time Price · USD
10.04
0.00 (0.00%)
At close: Dec 06, 2022, 5:26 PM
Company Description
Revolution Healthcare Acquisition Corp. does not have significant operations.
The company intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination.
It focuses on pursuing opportunities in health care, life sciences, and technology industries.
The company was incorporated in 2021 and is based in Cambridge, Massachusetts.
Revolution Healthcare Acquisition Corp.
| Country | United States |
| IPO Date | May 10, 2021 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Jay S. Markowitz |
Contact Details
Address: 20 University Road Cambridge, Massachusetts United States | |
| Website | https://revolutionhealthcareacqcorp.com |
Stock Details
| Ticker Symbol | REVH |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001841389 |
| CUSIP Number | 76155Y108 |
| ISIN Number | US76155Y1082 |
| Employer ID | 00-0000000 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Dr. Jay S. Markowitz M.D. | Chief Executive Officer & Director |
| Mark A. McDonnell CPA, CPA | Chief Financial Officer |
| Paul Fielding | Chief Operating Officer |
| Jason Doren | Chief Admin. Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 14, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Feb 06, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Dec 16, 2022 | 15-12G | Filing |
| Dec 12, 2022 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Dec 06, 2022 | 25-NSE | Filing |
| Dec 06, 2022 | 8-K | Current Report |
| Nov 28, 2022 | DEFA14A | Filing |
| Nov 28, 2022 | 8-K | Current Report |
| Nov 10, 2022 | 10-Q | Quarterly Report |
| Nov 07, 2022 | DEF 14A | Filing |